<html>
<head>PUBMED IDs for SAMSN1</head>
<body bgcolor='#C5F0F2'><h1>SAMSN1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17135279/'>The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.</a> December 1  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18074101/'>Gene dosage change of TPTE and BAGE2 and breakpoint analysis in Robertsonian Down syndrome.</a> December 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18523997/'>Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer.</a> June 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18778695/'>Molecular profiles of schizophrenia in the CNS at different stages of illness.</a> September 10  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20478393/'>SLy2 targets the nuclear SAP30/HDAC1 complex.</a> November 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24278465/'>SAMSN1 is highly expressed and associated with a poor survival in glioblastoma multiforme.</a> August 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25117979/'>SAMSN1 is a tumor suppressor gene in multiple myeloma.</a> April 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25805236/'>Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.</a> October 8  2015<br></body></html>
